Insiders/Lock-up impact:
% are before and after offering:
5% Stockholders
Oxford Bio IV affiliates 2,314,815 19.8 % 13.7 %
Lonmodtagernes Dyrtidsfond 1,123,952 9.6 6.7
OrbiMed Advisors 889,009 7.6 5.3
Dansk Kapitalanlaeg Aktieselskab 859,013 7.3 5.1
Kommunernes Pensionsforsikring A/S 704,264 6.0 4.2
Federated Kaufmann Fund 686,009 5.9 4.1
ABN AMRO Ventures BV 662,391 5.7 3.9
Hambrecht & Quist 609,671 5.2 3.6
Directors and Executive Officers
Uli Hacksell, Ph.D. 439,791 3.7 2.6
Mark R. Brann, Ph.D. 787,756 6.6 4.6
Thomas H. Aasen 204,635 1.7 1.2
Robert E. Davis, Ph.D. 167,359 1.4 1.0
Bo-Ragnar Tolf, Ph.D. 83,906 * *
Leslie L. Iversen, Ph.D. 17,750 * *
Alan G. Walton, Ph.D. 2,314,815 19.8 13.7
Carl L. Gordon, Ph.D. 889,009 7.6 5.3
Martien van Osch 662,391 5.7 3.9
Gordon Binder 555,555 4.7 3.3
Lester J. Kaplan, Ph.D. 511,500 4.4 3.0
Torsten Rasmussen 10,500 * *
directors & officers (13 persons) 6,756,633 53.0% 37.9% |
